Credit Suisse’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-49,704
| Closed | -$129K | – | 3172 |
|
|
2023
Q2 | $129K | Buy |
49,704
+12,122
| +32% | +$31.4K | ﹤0.01% | 3111 |
|
|
2023
Q1 | $153K | Buy |
37,582
+2,988
| +9% | +$12.2K | ﹤0.01% | 3148 |
|
|
2022
Q4 | $174K | Buy |
34,594
+6,885
| +25% | +$34.6K | ﹤0.01% | 3206 |
|
|
2022
Q3 | $362K | Buy |
27,709
+194
| +0.7% | +$2.53K | ﹤0.01% | 2969 |
|
|
2022
Q2 | $352K | Buy |
27,515
+2,961
| +12% | +$37.9K | ﹤0.01% | 3050 |
|
|
2022
Q1 | $374K | Sell |
24,554
-400
| -2% | -$6.09K | ﹤0.01% | 3113 |
|
|
2021
Q4 | $443K | Buy |
24,954
+5,845
| +31% | +$104K | ﹤0.01% | 3104 |
|
|
2021
Q3 | $402K | Buy |
19,109
+4,296
| +29% | +$90.4K | ﹤0.01% | 3125 |
|
|
2021
Q2 | $292K | Buy |
+14,813
| New | +$292K | ﹤0.01% | 3290 |
|